Publication | Closed Access

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

ObesityMetabolic SyndromeBody CompositionMetabolic DisorderPsychiatryMedicineDiabetesPsychopharmacologySchizophreniaWeight GainMetabolic ComplicationGerman SampleInsulin-induced Gene 2EndocrinologyPharmacologyHealth Sciences